Announcement on Preliminary Earnings Estimate for 2024
Filed with SSE · · 4 pages · Chinese
Dizal (Jiangsu) Pharmaceutical Co. Ltd. on 6ix
Earlier from Dizal (Jiangsu) Pharmaceutical
Later from Dizal (Jiangsu) Pharmaceutical
- Announcement on Documents like Prospectus (Registration Draft) for Issuance of Shares to Specific Objects
- Dizal's Golidocitinib in Combination with Anti-PD-1 Shows Promise in IO Resistant Non-Small Cell Lung Cancer
- Announcement on Resolution of the 1st Extraordinary General Meeting in 2025
- Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting
- Announcement on Correction to the Signing of Agreement on Supervision over Deposit in Special Account for Raised Funds
Follow Dizal (Jiangsu) Pharmaceutical into a list and get an email when it puts out news.
Follow Dizal (Jiangsu) Pharmaceutical